67 research outputs found
DRUG OR TOOL, DESIGN OR SERENDIPITY
Iterative protein structure-based ligand design has led to a 'selective' inhibitor of human non-pancreatic secretory phospholipase A2 which provides a new tool for probing metabolic pathways and may lead to a useful drug.
- …